K M C Speciality Hospitals (India) profit and loss

Latest FY24

Revenue: ₹177cr+13.8% on FY23
EBITDA: ₹47.4cr+14.7% on FY23
Net profit: ₹30.4cr+13.8% on FY23
EPS: ₹1.86+13.4% on FY23

₹ crore except per share

Tap a line for its trend	FY24Mar 2024	FY23Mar 2023	FY22Mar 2022	FY21Mar 2021	FY20 and earlierAlpha Plus

Expenses
	177	156	136	103	FY20 and earlierEvery year the company has filed comes with Alpha Plus.
	—	3.1	2.1	1.9
	181	159	138	—
	3.6	2.9	2.7	2.7
	20.7	20.4	17.9	—
	0.2	−0.3	−0.0	—
	38.3	31.2	27.1	21.5
	1.2	0.8	0.7	1.0
	9.2	7.6	6.5	6.2
	—	60.3	51.2	41.6
	140	123	—	—
	47.4	41.3	37.2	23.2
	38.2	33.7	30.6	17.1
Profit
	40.6	36.0	32.1	18.0
	8.8	9.9	8.4	5.7
	1.4	−0.7	−0.4	−0.4
	10.2	9.3	8.4	5.3
	30.4	26.7	23.7	12.8
	−0.3	—	—	—
	30.1	26.7	23.5	12.7
Per share
	₹1.86	₹1.64	₹1.45	₹0.78
	₹1.86	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	153	133	116	100.0
	86.2%	85.3%	84.9%	97.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersDRAGARWQ KOVAI LOTUSEYE GPTHEALTH GKSL SHALBY INDRAMEDCO ARTEMISMEDMcap ₹2,439 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY21 31/03/2021	FY22 31/03/2022	FY23 31/03/2023	FY24 31/03/2024
Revenue from Operations	102.6	136.1	155.8	177.2
Other Income	1.9	2.1	3.1	—
Total Income	—	138.2	158.9	180.7
Expenses
+ Cost of Materials Consumed	2.7	2.7	2.9	3.6
+ Purchases of Stock-in-Trade	—	17.9	20.4	20.7
+ Changes in Inventories	—	-0.0	-0.3	0.2
+ Employee Benefit Expense	21.5	27.1	31.2	38.3
+ Finance Costs	1.0	0.7	0.8	1.2
+ Depreciation & Amortisation	6.2	6.5	7.6	9.2
+ Other Expenses	41.6	51.2	60.3	—
Total Expenses	—	—	122.9	140.2
EBITDA	23.2	37.2	41.3	47.4
EBIT	17.1	30.6	33.7	38.2
Profit
Pretax Income	18.0	32.1	36.0	40.6
+ Current Tax	5.7	8.4	9.9	8.8
+ Deferred Tax	-0.4	-0.4	-0.7	1.4
Tax Expense	5.3	8.4	9.3	10.2
Net Income	12.8	23.7	26.7	30.4
+ Other Comprehensive Income	—	—	—	-0.3
Total Comprehensive Income	12.7	23.5	26.7	30.1
Per Share
Basic EPS	0.78	1.45	1.64	1.86
Diluted EPS	—	—	—	1.86
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	100.0	115.5	132.8	152.8
Gross Margin %	97.38	84.89	85.25	86.21

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.